Trial Profile
Phase III trial of a cardiac cell therapy (Monocell) in patients with treatment-refractory angina pectoris.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 21 Nov 2012
Price :
$35
*
At a glance
- Drugs Autologous diabetes stem cell therapy Cellonis Biotechnologies (Primary)
- Indications Angina pectoris
- Focus Registrational; Therapeutic Use
- 21 Nov 2012 New trial record